Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis

OBJECTIVE: Antiphospholipid syndrome (APS) is a chronic autoimmune disease with a high prevalence in females. Published data have identified pregnant women with APS may suffer from recurrent miscarriage, fetal death. However, the association between antiphospholipid antibody (aPL) and fetal growth r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jinfeng, Chen, Daijuan, Tian, Yuan, Wang, Xiaodong, Peng, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159204/
https://www.ncbi.nlm.nih.gov/pubmed/35685559
http://dx.doi.org/10.1155/2022/4308470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159204/
https://www.ncbi.nlm.nih.gov/pubmed/35685559
http://dx.doi.org/10.1155/2022/4308470

Ejemplares similares